Remove 2022 Remove Consumption Remove Oil Remove Seed-To-Sale
article thumbnail

Cannabis laws in Luxembourg

The Cannigma

Plans were first announced in 2018 and a draft of the legislation was released to the public in June 2022. The proposed law would allow residents to cultivate up to four plants and consume at home, but public consumption remains illegal. Proposed regulations were introduced in 2022. Public consumption is still illegal.

Law 52
article thumbnail

Washington Cannabis: The Proposed Hemp Overhaul is Here

Canna Law Blog

Washington’s hemp law is also extremely confusing thanks to RCW 15.120.020 which prohibits the “production of any part of industrial hemp, except seed, as food, extract, oil, cake, concentrate, resin, or other preparation for topical use, oral consumption, or inhalation by humans[.]”

Hemp 71
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD Ban: Brits Take Up Fight And Send Lawyers To Brussels

Cannabis Law Report

Cannabis lawyers are heading to Brussels next week to challenge a recent decision by the European Union to reclassify food products containing cannabidiol (CBD) and prohibit their sale. In the case of CBD, this includes extracts, oils and other derived products that are intended for ingestion by humans. AUTHOR: Mark Taylor.

CBD 87
article thumbnail

What Going Green Means for the Golden State and the Rest of the World

CannaTech

The bill, scheduled to take effect on January 1, 2019, allows California farmers to enter the rapidly-growing hemp industry on a wide scale, raising industrial hemp to produce hemp seed, oil, fiber, and extract for a variety of uses. These are some of the iconic images that immediately come to mind when people think of California.

Hemp 53
article thumbnail

Columbia Care Completes Acquisition of Green Leaf Medical; Cements Market Leading Position in Mid-Atlantic

Cannabis Law Report

Total upfront consideration was approximately $240 million, comprised of $45 million in cash and $195 million in Columbia Care stock, with the potential for additional performance-based milestones in 2022 and 2023. 2021 Adjusted EBITDA. This transaction is immediately accretive to gross margin, Adjusted EBITDA and cash flow from operations.

article thumbnail

CBD Chaos in Spain

Sensi Seeds

Spain’s cannabis market is a diverse mix of Spanish and foreign-owned companies selling everything from seeds, fertilizer and grow lamps to hemp-infused beers and CBD tinctures, oils, and creams. They cannot sell any cannabis product with a tetrahydrocannabinol (THC) content higher than 0.2% Rumors, Statements and Raids ??

CBD 71
article thumbnail

Columbia Care Reports Record Third Quarter 2021 Results

Cannabis Law Report

We see momentum building into 2022 and beyond as we optimize our national portfolio and launch brands throughout our markets.”. Record Adjusted EBITDA of $31.0 Million, an increase of 634% YoY, 89% QoQ. Record Adjusted EBITDA Margin of 23%, an increase of 1,564bps YoY, 848bps QoQ. NEW YORK–(BUSINESS WIRE)–Columbia Care Inc.